Showing 481 - 500 results of 624 for search '"chronic obstructive pulmonary disease"', query time: 0.06s Refine Results
  1. 481

    Progress of CCL20-CCR6 in the airways: a promising new therapeutic target by Ya -Jing Li, Wan-Li Geng, Chen-Chen Li, Jia-Hao Wu, Fei Gao, Yong Wang

    Published 2024-12-01
    “…Within the respiratory system, CCL20-CCR6 demonstrates heightened expression in conditions such as allergic asthma, chronic airway inflammation, non-small cell lung cancer (NSCLC), chronic obstructive pulmonary disease (COPD), and other respiratory diseases, which is conducive to the inflammatory mediators recruitment and tumor microenvironment remodeling. …”
    Get full text
    Article
  2. 482

    Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology by Elena Carmona-Rocha, Lluís Rusiñol, Lluís Puig

    Published 2025-01-01
    “…Roflumilast is a PDE4 inhibitor that was approved by the FDA and the EMA as an oral treatment of chronic obstructive pulmonary disease. Since patent expiration, several generic formulations of oral roflumilast have become available, and various studies have documented its off-label use in psoriasis and other dermatological conditions such as hidradenitis suppurativa, recurrent oral aphthosis, nummular eczema, lichen planus, and Behçet’s disease. …”
    Get full text
    Article
  3. 483

    Acute Deterioration of Pulmonary Arterial Hypertension (PAH) in a Patient with Neurofibromatosis Type 1 (NF1) by Seiya Tanaka, Fuko Kawahara, Taro Miyamoto, Satoshi Tsurusaki, Yoshihito Sanuki, Kiyoshi Ozumi, Takashi Harada, Hiromi Tasaki

    Published 2019-01-01
    “…A 56-year-old woman was diagnosed as having chronic obstructive pulmonary disease with heavy smoking. Mild pulmonary hypertension (mean pulmonary arterial pressure: 31 mmHg) was detected at the first visit. …”
    Get full text
    Article
  4. 484

    Regional risk factors associated with adverse outcomes of COVID-19 infection among the older adult: A systematic review and meta-analysis by Olunike Rebecca Abodunrin, Mobolaji Timothy Olagunju, Xinyi Huang, Jianming Wang, Zhibin Hu, Chong Shen

    Published 2025-02-01
    “…Key factors include old age (above 65 years), male gender, symptoms such as fever and dyspnea, and comorbidities like dementia, chronic obstructive pulmonary disease (COPD), chronic heart disease, hypertension, chronic kidney disease, and malnutrition. …”
    Get full text
    Article
  5. 485

    Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD by Brittany M. Salter, Fizza Manzoor, Suzanne Beaudin, Melanie Kjarsgaard, Parameswaran Nair, Gail M. Gauvreau, Roma Sehmi

    Published 2016-01-01
    “…Chronic obstructive pulmonary disease (COPD) is characterized by fixed airflow limitation and progressive decline of lung function and punctuated by occasional exacerbations. …”
    Get full text
    Article
  6. 486

    Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and After Exacerbation by Mayr W, Triantafyllopoulos A, Batliner A, Schuller BW, Berghaus TM

    Published 2025-01-01
    “…Wolfgang Mayr,1,* Andreas Triantafyllopoulos,2,3,* Anton Batliner,2,3 Björn W Schuller,2– 5 Thomas M Berghaus1,6 1Department of Cardiology, Respiratory Medicine and Intensive Care, University Hospital Augsburg, Augsburg, Germany; 2Chair of Health Informatics (CHI), Department of Clinical Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; 3Munich Center for Machine Learning (MCML), Munich, Germany; 4Group on Language Audio, & Music (GLAM), Imperial College, London, UK; 5Munich Data Science Institute (MDSI), Munich, Germany; 6Medical Faculty, Ludwig Maximilians University of Munich, Munich, Germany*These authors contributed equally to this workCorrespondence: Wolfgang Mayr, Department of Cardiology, Respiratory Medicine and Intensive Care, University Hospital Augsburg, Stenglinstrasse 2, Augsburg, D-86156, Germany, Email wolfgang.mayr@uk-augsburg.de Andreas Triantafyllopoulos, Chair of Health Informatics, Department of Clinical Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, Munich, 81675, Germany, Email andreas.triantafyllopoulos@tum.deBackground: Chronic obstructive pulmonary disease (COPD) affects breathing, speech production, and coughing. …”
    Get full text
    Article
  7. 487

    Megestrol acetate for appetite stimulation and weight gain in older adults with unintentional weight loss: a systematic review and meta-analysis by Larissa de Freitas do Lago-Abreu, Raphael Lopes Olegário, Luciana Lilian Louzada Martini, Einstein Francisco Camargos

    Published 2025-01-01
    “…Unintentional weight loss in older adults is linked to multiple factors, being most often associated with comorbidities such as cancer, dementia syndromes, chronic obstructive pulmonary disease, and chronic kidney disease. …”
    Get full text
    Article
  8. 488

    EFFORTS IN CONTROLLING COAL DUST HAZARDS IN THE STOCKPILE AREA OF A STEAM POWER PLANT (PLTU) by Alifiah Rizky Rosydah, Y. Denny Ardyanto Wahyudiono, Ahmad Imaduddin, Dani Nasirul Haqi, Meirina Ernawati

    Published 2022-11-01
    “…The smaller the particle size, the more harmful effects it can have on human health, such as bronchitis, decreased lung function, Chronic Obstructive Pulmonary Disease (COPD), Coal Worker's Pneumoconiosis (CWP), and other respiratory diseases. …”
    Get full text
    Article
  9. 489
  10. 490

    Demographic and Clinical Presentation of Hospitalised Patients with SARS-CoV-2 During the First Omicron Wave by Mehool Patel, Elizabeth Aitken

    Published 2022-11-01
    “…Common COVID-19 presentations included delirium, falls, seizures, chronic obstructive pulmonary disease, and antenatal problems. Overall, 13.7% (76/553) patients died and 4.7% (26/553) were directly attributable to COVID-19. …”
    Get full text
    Article
  11. 491

    Neuropeptides SP and CGRP Diminish the Moraxella catarrhalis Outer Membrane Vesicle- (OMV-) Triggered Inflammatory Response of Human A549 Epithelial Cells and Neutrophils by Daria Augustyniak, Justyna Roszkowiak, Izabela Wiśniewska, Jacek Skała, Daiva Gorczyca, Zuzanna Drulis-Kawa

    Published 2018-01-01
    “…Moraxella catarrhalis is one of the leading infectious agents responsible for inflammatory exacerbation in chronic obstructive pulmonary disease (COPD). Since the airway inflammation in COPD is connected with activation of both epithelial cells and accumulated neutrophils, in this study we determined the in vitro effects of neuropeptides on the inflammatory potential of these cells in response to M. catarrhalis outer membrane vesicle (OMV) stimulant. …”
    Get full text
    Article
  12. 492

    Clinical Predictors of Hospital-acquired Pneumonia Associated with Acute Ischemic by Alexis Suárez Quesada, Ezequiel López Espinosa, Noelsis García Verdecia, Miguel Ángel Serra Valdés

    Published 2015-06-01
    “…The following independent factors were identified: Glasgow Coma Scale ≤ 11 (OR: 26.099; 95 % CI 7.164-85.075), history of chronic obstructive pulmonary disease (OR: 8.896; 95 % CI 1.203-65.779), dysphagia (OR: 7.652; 95 % CI 2.369- 24.720), history of heart failure (OR: 4.583; 95 % CI 1.240- 16.932) and dysarthria/severe motor aphasia (OR: 4.222; 95 % CI 1.374- 12.975). …”
    Get full text
    Article
  13. 493

    A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection by Angela Branche, Mayur Ramesh, Beverly Francis

    Published 2024-12-01
    “…., congestive heart failure) and respiratory diseases (e.g., chronic obstructive pulmonary disease), diabetes, chronic kidney disease, and obesity, are key factors that predispose individuals to SARS-CoV-2-, influenza-, and RSV-related severe outcomes. …”
    Get full text
    Article
  14. 494

    Association Between Platelet-Albumin-Bilirubin Grade and the 30-Day Mortality in Patients with Acute Respiratory Distress Syndrome: Evidence from the MIMIC-IV Database by Dandan Ye, Wei Jiang, Deming Gu

    Published 2025-01-01
    “…High PALBI grade was related to higher odds of 30-day mortality in patients with ARDS aged ≥ 65 years (HR: 2.30, 95% CI: 1.06-5.01), males (HR: 2.10, 95% CI: 1.29-3.44), without sepsis (HR: 1.71, 95% CI: 1.11-2.64), without pneumonia (HR: 1.86, 95% CI: 1.19-2.91), and without any history of chronic obstructive pulmonary disease (HR: 1.93, 95% CI: 1.28-2.91). …”
    Get full text
    Article
  15. 495

    Development and validation of a novel AI-derived index for predicting COPD medical costs in clinical practice by Guan-Heng Liu, Chin-Ling Li, Chih-Yuan Yang, Shih-Feng Liu

    Published 2025-01-01
    “…Background: Chronic Obstructive Pulmonary Disease (COPD) is a major contributor to global morbidity and healthcare costs. …”
    Get full text
    Article
  16. 496

    NLRP3 is a BMI-independent mediator of stable COPD by Yonca Gungor, Selin Ercan, Saliha Selin Özuygur Ermiş, Yiğit Kozalı, Gizem Kursunluoglu, Ceyda Sahan, Aylin Ozgen Alpaydin, Hulya Ayar Kayali

    Published 2025-01-01
    “…Abstract Purpose The inflammatory response in animal models of chronic obstructive pulmonary disease (COPD) is activated by the NLR-family-pyrin-domain-containing-3 (NLRP3) inflammasome pathway, which is also known to play a role in obesity-related inflammation. …”
    Get full text
    Article
  17. 497

    Malondialdehyde in Exhaled Breath Condensate as a Marker of Oxidative Stress in Different Pulmonary Diseases by M. L. Bartoli, F. Novelli, F. Costa, L. Malagrinò, L. Melosini, E. Bacci, S. Cianchetti, F. L. Dente, A. Di Franco, B. Vagaggini, P. L. Paggiaro

    Published 2011-01-01
    “…We measured MDA levels in EBC in a large number of patients (N=194) with respiratory diseases: asthma (N=64), bronchiectasis (BE, N=19), chronic obstructive pulmonary disease (COPD, N=73), idiopathic pulmonary fibrosis (IPF, N=38). …”
    Get full text
    Article
  18. 498

    Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects by Woo Jin Kim, Jae Hyun Lim, Jae Seung Lee, Sang-Do Lee, Ju Han Kim, Yeon-Mok Oh

    Published 2015-01-01
    “…Background and Objectives. Chronic obstructive pulmonary disease (COPD) is a complex disease characterized by airflow limitation. …”
    Get full text
    Article
  19. 499

    Correlation of Platelet Indices with Severity of Gastroesophageal Varices in Patients of Liver Cirrhosis: A Research Protocol by Parav Tantia, Sourya Acharya

    Published 2025-02-01
    “…Initial parameters will include age, gender, weight, co-morbidities (such as Diabetes Mellitus (DM), Hypertension (HTN), Heart Failure (HF), Cardiovascular Disease (CVS), Chronic Obstructive Pulmonary Disease (COPD), kidney failure, liver failure, and malignant conditions), and the aetiology of cirrhosis. …”
    Get full text
    Article
  20. 500

    Unveiling the Prognostic Power of HRR in ICU-Admitted COPD Patients: A MIMIC-IV Database Study by Wang Y, Chen D, Zhang C, Yang H

    Published 2025-01-01
    “…Yuan Wang,1 Dan Chen,2 Chunlu Zhang,3 Haiying Yang1 1Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Meishan City, Meishan, Sichuan, 620500, People’s Republic of China; 2Department of Respiratory Medicine, Yunchang Hospital, Meishan, Sichuan, 620500, People’s Republic of China; 3Department of Geriatrics, Chengdu Sixth People’s Hospital, Chengdu, Sichuan, 610051, People’s Republic of ChinaCorrespondence: Yuan Wang, Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Meishan City, Meishan, Sichuan, 620500, People’s Republic of China, Email 2693855887@qq.comObjective: This study sought to examine the potential relationship between Hemoglobin/Red Cell Distribution Width Ratio (HRR) and the all-cause mortality risk in critically ill patients with chronic obstructive pulmonary disease (COPD).Patients and Methods: In a retrospective analysis of the MIMIC-IV database, patients were divided into two groups based on a specific HRR threshold. …”
    Get full text
    Article